Comment: COVID-19 vaccines: neutralizing antibodies and the alum advantage.

04 Jun 2020
Hotez PJ, Corry DB, Strych U, Bottazzi ME

Achieving high levels of neutralizing antibodies to the spike protein of SARS-CoV-2 in a safe manner is likely to be crucial for an effective vaccine. Here, we propose that aluminium-based adjuvants might hold the key to this.